Learn more
Cefoperazone/Sulbactam: Extended coverage with β-lactamase inhibition
Recommended dosage in adult and special population
Cefoperazone/Sulbactam is recommended as an effective and well-tolerated antibiotic
Explore the safety profile of cefoperazone/sulbactam
Cefoperazone/Sulbactam is more efficient in the treatment of infection
Cefoperazone/Sulbactam is one of the recommended antibiotics by the ICMR and SIS
Manage IAI with cefoperazone/sulbactam
ICMR recommended (2019) antibiotics for the treatment of UTI
Manage RTI with cefoperazone/sulbactam
Cefoperazone/Sulbactam is a good option in high-risk patients with FN
MAGNEX® is recommended by clinical practice guidelines
Pfizer Limited
The Capital – A Wing, 1802, 18th Floor, Plot
No. C-70, G Block, Bandra Kurla Complex,
Bandra (East), Mumbai – 400 051, India.
®Trademark Proprietor – Pfizer Products Inc.,
USA
Licensed User – Pfizer Limited, India
To view the summary of prescribing
information for MAGNEX®, please click here
BL, β-lactamase; BLI, β-lactamase inhibitor; FN, febrile neutropenia; IAI, intra-abdominal infection; ICMR, Indian Council of Medical Research; RTI, respiratory tract infection; SIS, Surgical Infection Society; UTI, urinary tract infection.
Reference:
1. Magnex. Local product document. Pfizer; 2020. Version LPDMGX042020.
Please click the Prescribing Information link to view the safety and adverse events information of MAGNEX®.
For the use only of Registered Medical Practitioners or a Hospital or a Laboratory.
To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Hac habitasse platea dictumst quisque sagittis purus sit amet volutpat. Lectus magna fringilla urna porttitor rhoncus. Venenatis urna cursus eget nunc scelerisque viverra. Id donec ultrices tincidunt arcu non sodales.
Sagittis aliquam malesuada bibendum arcu vitae elementum curabitur. Pellentesque elit ullamcorper dignissim cras tincidunt. Orci ac auctor augue mauris augue neque. Dui vivamus arcu felis bibendum ut tristique et egestas quis. Sed vulputate mi sit amet mauris commodo.
Nunc eget lorem dolor sed viverra ipsum. Sed ullamcorper morbi tincidunt ornare.
These pages are not intended for patients or for members of the general public. The web pages contain promotional content.
If you select 'No', you will be redirected to Pfizer.co.in
For more details on, Who is a Registered medical practitioner*, please visit https://cdsco.gov.in/opencms/export/sites/CDSCO_WEB/Pdf-documents/acts_rules/2016DrugsandCosmeticsAct1940Rules1945.pdf , Page No. 39, Rule 2 part (ee), last accessed on 26th April 2021.
Address: The Capital, A Wing, 1802, 18th Floor, Plot No. C-70, 'G' Block, Bandra Kurla Complex, Bandra East, Mumbai - 400051.